A study of the effects of extracorporeal circulation on the immunologic system of humans

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 10, Issue 7, 1996, Pages 893-898

  Siminelakis, S ^a   Bossinakou, I ^a   Antoniou, F ^a   Pallanza, Z ^a   Tolios, J ^a   Vasilogiannakopoulou, D ^a   Kasapli, M ^a   Parigori, P ^a   Chlapoutakis, E ^a  

^a Cardiac Surgeon   (Greece)

Author keywords

cardiopulmonary bypass; immunology

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; FENTANYL; FLUNITRAZEPAM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M; MORPHINE; PANCURONIUM;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CELLULAR IMMUNITY; CLINICAL ARTICLE; EXTRACORPOREAL CIRCULATION; FEMALE; HEART SURGERY; HUMAN; HUMORAL IMMUNITY; MALE; PRIORITY JOURNAL; VALVULAR HEART DISEASE;

EID: 0029751979     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(96)80052-8     Document Type: Article

References (41)

1. Kirklin JW Barratt-Boyes BG Cardiac Surgery (ed 2) 1993 Churchill Livingstone New York 83 85
2. Kirklin K Westaby S Blackstone H Complement and the damaging effect of cardiopulmonary bypass J Thorac Cardiovascular Surg 86 1983 845 857
3. Chenoweth DE Cooper SW Hugli TE Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins N Engl J Med 304 1981 497 503
4. Finn A Naik S Klein N Interleukin-8 release and neutrophil degranulation after paediatric cardiopulmonary bypass J Thorac Cardiovasc Surg 105 1993 234 241
5. Addonizio VP Strauss JF Chang LF Release of lysosomal hydrolases during simulated extracorporeal circulation J Thorac Cardiovasc Surg 84 1982 28 34
6. Smith E Naftel D Blackstone E Microvascular permeability after cardiopulmonary bypass: An experimental study J Thorac Cardiovasc Surg 94 1987 225 233
7. Hisatomi K Isomura T Kawara T Changes in lymphocytes subsets, mitogen responsiveness and interleukin-2 production after cardiac operations J Thorac Cardiovasc Surg 98 1989 580 591
8. Markewitz A Faist E Weinhold G Alterations of cell-mediated immune response following cardiac surgery Eur J Cardiothorac Surg 7 1993 193 199
9. Markewitz A Faist E Niesel T Changes in lymphocyte subsets and mitogen responsiveness following open-heart surgery and possible therapeutic approaches J Thorac Cardiovasc Surg 40 1992 14 18
10. Faist E Markewitz A Fuchs D Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery Ann Surg 214 1991 264 275
11. Jansen N Van Oeveren N V.d. Bzoek L Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass J Thorac Cardiovasc Surg 102 1991 515 525
12. De Gowin EL De Gowin RL Bedside Diagnostic Examination (ed 3) 1976 Macmillan New York 39 40
13. Merlini G Aguzzi F The laboratory investigation of monoclonal components Haematologica 73 1988 79 85
14. Check IG Piper M Quantitation of immunologlobulins Rose NR Friedman H Fahey J Manual of Clinical Laboratory Immunology (ed 3) 1986 American Society for Microbiology Washington, DC 138 151
15. Kim YR Martin G Paseltiner L Subtyping lymphocytes in peripheral blood by immunoperoxidase labeling and light scatter/absorption flow cytometry Clin Chem 31 1985 1481 1486
16. Kjeldsberg KR Principles of hematologic examination Lee GR Bithell TC Foerster J Wintrobe's Clinical Hematology (ed 9) 1993 Lea and Febiger Philadelphia 7 23
17. Bell DM Goldmann DA Hopkins CC Unreability of fever and leukocytosis in the diagnosis of infection after cardiac valve surgery J Thorac Cardiovasc Surg 75 1978 87 90
18. Wilson AP Treasure T Gruneberg RN Should the temperature chart influence management in cardiac operation? Result of a prospective study in 314 patients J Thorac Cardiovasc Surg 96 1988 518 523
19. Tulla H Takala J Alhava E Hypermetabolism after coronary artery bypass J Thorac Cardiovasc Surg 101 1991 598 600
20. Khuri SF Wolfe A Josa M Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss J Thorac Cardiovasc Surg 104 1992 94 107
21. Gaither TA Frank MM Complement Henry JB Clinical Diagnosis and Management by Laboratory Methods (ed 18) 1991 Saunders Philadelphia 833
22. Clark RE Beauchamp RA Magrath RA Comparison of bubble and membrane oxygenators in short and long perfusions J Thorac Cardiovasc Surg 78 1979 655 666
23. Roitt I Brostoff J Male D Immunology (ed 3) 1993 Mosby London 12.1 12.17
24. Craddock PR Fehr J Brigham KL Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis N Engl J Med 296 1977 769 774
25. Boonstra PW Vermeulen FE Leusink JA Haematological advantage of a membrane oxygenator over a bubble oxygenator in long perfusions Ann Thorac Surg 41 1986 297 300
26. Walter JB Pathology of Human Disease (ed 1) 1989 Lea and Febiger Philadelphia 61 62
27. Miller JL Blood coagulation and fibrinolysis Henry JB Clinical Diagnosis and Management by Laboratory Methods (ed 18) 1991 Saunders Philadelphia 734 757
28. Mc Millen MA Coagulation Cerra FB Manual of Critical Care 1987 Mosby St Louis, MO 244 270
29. Donnelly PK Shenton BK Alomran AH The role of protease in immunoregulation Br J Surg 70 1983 614 622
30. Lennard TW Shenton BK Borzotta A The influence of surgical operations on components of the human immune system Br J Surg 72 1985 771 776
31. Frank MM Complement Stites DP Terr AI Parslow TG Basic and Clinical Immunology (ed 8) 1994 Appleton and Lange East Norwalk, CT 124 136
32. Butler J Pillai R Rocker GM Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor J Thorac Cardiovasc Surg 105 1993 25 30
33. Brewster N Guthrie C McBirnie J CRP levels as a measure of surgical trauma: A comparison of different general surgical procedures J R Coll Surg Edinb 39 1994 86 88
34. Cavarocchi NC Pluth JR Schaff HV Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators J Thorac Cardiovasc Surg 91 1986 252 258
35. Termuhlen DF Pennington G Roodman ST T cells in ventricular assist device patients Circulation 80 suppl 3 1989 174 182
36. Markewitz A Faist E Lang S Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation J Thorac Cardiovasc Surg 105 1993 15 25
37. 2 production in severely injured patients Arch Surg 123 1988 293 299
38. Ganong WF Review of Medical Physiology (ed 17) 1995 Appleton and Lange East Norwalk, CT 231
39. Tennenberg SD Bailey WW Cotta LA The effects of methyl prednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass Surgery 100 1986 134 142
40. Bando K Pillai R Cameron D Leukocyte depletion ameliorates free-radical mediated lung injury after cardiopulmonary bypass J Thorac Cardiovasc Surg 99 1990 873 877
41. Breda MA Drinkwater DC Laks H Prevention of reperfusion injury in the neonatal heart with leukocyte-depleted blood J Thorac Cardiovasc Surg 97 1989 654 665